Therapeutic goals in patients with pheochromocytoma: a guide to perioperative management

N. Azadeh, Harish Ramakrishna, N. L. Bhatia, J. C. Charles, F. Mookadam

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Pheochromocytomas are rare neuroendocrine tumors of the adrenal medulla that may present with protean manifestations. Surgical resection is the mainstay of therapy and patients are at risk of significant hemodynamic and circulatory complications mainly attributable to catecholamine excess. The mainstay of medical therapy in order to optimize patients for surgery includes: alpha-blockers, beta-blockers, calcium channel blocker and other agents to achieve normal blood pressure, heart rate, as well as normal volume status. Understanding the pathophysiology of pheochromocytoma, the pharmacology of medications used, and recognizing postoperative complications will impact patient outcomes. Conclusion: A multidisciplinary team approach is best throughout the perioperative period to prevent potential complications that arise. The hospital physician, intensivist, anesthetist and cardiovascular specialist play a pivotal role in the management of patients with pheochromocytoma. In addition to the pharmacologic and volume recommendations, a multidisciplinary discussion allows for seamless implementation of an organized plan of care.

Original languageEnglish (US)
Pages (from-to)43-49
Number of pages7
JournalIrish Journal of Medical Science
Volume185
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Pheochromocytoma
Perioperative Period
Adrenal Medulla
Neuroendocrine Tumors
Calcium Channel Blockers
Therapeutics
Catecholamines
Heart Rate
Hemodynamics
Pharmacology
Blood Pressure

Keywords

  • Hemodynamics
  • Neuroendocrine tumors
  • Perioperative
  • Pheochromocytoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Therapeutic goals in patients with pheochromocytoma : a guide to perioperative management. / Azadeh, N.; Ramakrishna, Harish; Bhatia, N. L.; Charles, J. C.; Mookadam, F.

In: Irish Journal of Medical Science, Vol. 185, No. 1, 01.02.2016, p. 43-49.

Research output: Contribution to journalArticle

Azadeh, N. ; Ramakrishna, Harish ; Bhatia, N. L. ; Charles, J. C. ; Mookadam, F. / Therapeutic goals in patients with pheochromocytoma : a guide to perioperative management. In: Irish Journal of Medical Science. 2016 ; Vol. 185, No. 1. pp. 43-49.
@article{268334000c354e6daae0b9fb5c8d0c4b,
title = "Therapeutic goals in patients with pheochromocytoma: a guide to perioperative management",
abstract = "Introduction: Pheochromocytomas are rare neuroendocrine tumors of the adrenal medulla that may present with protean manifestations. Surgical resection is the mainstay of therapy and patients are at risk of significant hemodynamic and circulatory complications mainly attributable to catecholamine excess. The mainstay of medical therapy in order to optimize patients for surgery includes: alpha-blockers, beta-blockers, calcium channel blocker and other agents to achieve normal blood pressure, heart rate, as well as normal volume status. Understanding the pathophysiology of pheochromocytoma, the pharmacology of medications used, and recognizing postoperative complications will impact patient outcomes. Conclusion: A multidisciplinary team approach is best throughout the perioperative period to prevent potential complications that arise. The hospital physician, intensivist, anesthetist and cardiovascular specialist play a pivotal role in the management of patients with pheochromocytoma. In addition to the pharmacologic and volume recommendations, a multidisciplinary discussion allows for seamless implementation of an organized plan of care.",
keywords = "Hemodynamics, Neuroendocrine tumors, Perioperative, Pheochromocytoma",
author = "N. Azadeh and Harish Ramakrishna and Bhatia, {N. L.} and Charles, {J. C.} and F. Mookadam",
year = "2016",
month = "2",
day = "1",
doi = "10.1007/s11845-015-1383-5",
language = "English (US)",
volume = "185",
pages = "43--49",
journal = "The Dublin Journal of Medical and Chemical Science",
issn = "0332-1029",
publisher = "Springer London",
number = "1",

}

TY - JOUR

T1 - Therapeutic goals in patients with pheochromocytoma

T2 - a guide to perioperative management

AU - Azadeh, N.

AU - Ramakrishna, Harish

AU - Bhatia, N. L.

AU - Charles, J. C.

AU - Mookadam, F.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Introduction: Pheochromocytomas are rare neuroendocrine tumors of the adrenal medulla that may present with protean manifestations. Surgical resection is the mainstay of therapy and patients are at risk of significant hemodynamic and circulatory complications mainly attributable to catecholamine excess. The mainstay of medical therapy in order to optimize patients for surgery includes: alpha-blockers, beta-blockers, calcium channel blocker and other agents to achieve normal blood pressure, heart rate, as well as normal volume status. Understanding the pathophysiology of pheochromocytoma, the pharmacology of medications used, and recognizing postoperative complications will impact patient outcomes. Conclusion: A multidisciplinary team approach is best throughout the perioperative period to prevent potential complications that arise. The hospital physician, intensivist, anesthetist and cardiovascular specialist play a pivotal role in the management of patients with pheochromocytoma. In addition to the pharmacologic and volume recommendations, a multidisciplinary discussion allows for seamless implementation of an organized plan of care.

AB - Introduction: Pheochromocytomas are rare neuroendocrine tumors of the adrenal medulla that may present with protean manifestations. Surgical resection is the mainstay of therapy and patients are at risk of significant hemodynamic and circulatory complications mainly attributable to catecholamine excess. The mainstay of medical therapy in order to optimize patients for surgery includes: alpha-blockers, beta-blockers, calcium channel blocker and other agents to achieve normal blood pressure, heart rate, as well as normal volume status. Understanding the pathophysiology of pheochromocytoma, the pharmacology of medications used, and recognizing postoperative complications will impact patient outcomes. Conclusion: A multidisciplinary team approach is best throughout the perioperative period to prevent potential complications that arise. The hospital physician, intensivist, anesthetist and cardiovascular specialist play a pivotal role in the management of patients with pheochromocytoma. In addition to the pharmacologic and volume recommendations, a multidisciplinary discussion allows for seamless implementation of an organized plan of care.

KW - Hemodynamics

KW - Neuroendocrine tumors

KW - Perioperative

KW - Pheochromocytoma

UR - http://www.scopus.com/inward/record.url?scp=84954403055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954403055&partnerID=8YFLogxK

U2 - 10.1007/s11845-015-1383-5

DO - 10.1007/s11845-015-1383-5

M3 - Article

C2 - 26650752

AN - SCOPUS:84954403055

VL - 185

SP - 43

EP - 49

JO - The Dublin Journal of Medical and Chemical Science

JF - The Dublin Journal of Medical and Chemical Science

SN - 0332-1029

IS - 1

ER -